MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-19-2025
Dynatronics Corporation Total Current Liabilities 2011-2026 | DYNT
Annual Total Current Liabilities Dynatronics Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8.24 M | 7.7 M | 7.94 M | 9.94 M | 8.47 M | 7.68 M | 14.3 M | 14.6 M | 7.64 M | 3.93 M | 5.57 M | 7.03 M | 7.33 M | 7.09 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 14.6 M | 3.93 M | 8.39 M |
Total Current Liabilities of other stocks in the Medical devices industry
| Issuer | Total Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Cutera
CUTR
|
87.7 M | - | -10.19 % | $ 1.99 M |  USA |
 |
EDAP TMS S.A.
EDAP
|
37.8 M | - | - | $ 162 M |  France |
 |
GenMark Diagnostics, Inc.
GNMK
|
44.1 M | - | - | $ 1.77 B | USA |
 |
Avinger
AVGR
|
19.3 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
45.8 M | - | - | $ 3.31 B | USA |
 |
Eargo
EAR
|
25.3 M | - | - | $ 10.2 M | USA |
 |
Allied Healthcare Products
AHPI
|
5.98 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
5.05 M | - | -5.86 % | $ 30.6 M | USA |
 |
ClearPoint Neuro
CLPT
|
10.8 M | $ 13.58 | 1.04 % | $ 385 M | USA |
 |
Apollo Endosurgery
APEN
|
39.5 M | - | - | $ 475 M | USA |
 |
Alphatec Holdings
ATEC
|
219 M | $ 8.3 | 0.18 % | $ 1.25 B | USA |
 |
Aziyo Biologics
AZYO
|
25.1 M | - | 1.37 % | $ 20.5 M | USA |
 |
BioSig Technologies
BSGM
|
42.8 M | - | 37.08 % | $ 85.7 M | USA |
 |
BIOLASE
BIOL
|
19.7 M | - | -13.19 % | $ 166 K | USA |
 |
Conformis
CFMS
|
14.1 M | - | - | $ 16.4 M | USA |
 |
Cardiovascular Systems
CSII
|
40 M | - | 0.15 % | $ 844 M | USA |
 |
IRIDEX Corporation
IRIX
|
13.2 M | $ 1.13 | 0.89 % | $ 19.1 M | USA |
 |
Helius Medical Technologies
HSDT
|
3.02 M | $ 1.77 | 14.61 % | $ 39 M | USA |
 |
CryoLife, Inc.
CRY
|
60.5 M | - | -4.14 % | $ 702 M | USA |
 |
Cytosorbents Corporation
CTSO
|
9.71 M | $ 0.43 | 7.85 % | $ 26.8 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
46.2 M | $ 17.89 | 0.39 % | $ 420 M | USA |
 |
Delcath Systems
DCTH
|
11 M | $ 11.95 | 1.96 % | $ 428 M | USA |
 |
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.19 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
18 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
17.3 M | - | - | $ 462 M | USA |
 |
LivaNova PLC
LIVN
|
808 M | $ 80.29 | 1.13 % | $ 4.38 B |  Britain |
 |
LENSAR
LNSR
|
40.6 M | $ 5.78 | -0.77 % | $ 69.1 M | USA |
 |
Pulmonx Corporation
LUNG
|
20.1 M | $ 1.34 | -2.19 % | $ 54.5 M | USA |
 |
Electromed
ELMD
|
10.5 M | $ 37.94 | 2.15 % | $ 321 M | USA |
 |
MiMedx Group
MDXG
|
64.3 M | $ 3.72 | 3.19 % | $ 550 M | USA |
 |
Butterfly Network
BFLY
|
65.1 M | $ 5.71 | 2.98 % | $ 1.41 B | USA |
 |
Intersect ENT, Inc.
XENT
|
44.2 M | - | - | $ 955 M | USA |
 |
Second Sight Medical Products
EYES
|
6.6 M | - | -0.97 % | $ 54.4 M | USA |
 |
Myomo
MYO
|
8.35 M | $ 1.33 | 15.65 % | $ 55.7 M | USA |
 |
GBS
GBS
|
5.35 M | - | -0.57 % | $ 7.12 M | USA |
 |
Orthofix Medical
OFIX
|
170 M | $ 9.28 | -0.32 % | $ 368 M |  Curacao |
 |
Globus Medical
GMED
|
498 M | $ 77.54 | -3.55 % | $ 10.5 B | USA |
 |
Profound Medical Corp.
PROF
|
6.08 M | $ 6.9 | 4.15 % | $ 209 M |  Canada |
 |
Insulet Corporation
PODD
|
680 M | $ 149.16 | -0.36 % | $ 10.5 B | USA |
 |
CONMED Corporation
CNMD
|
315 M | $ 34.57 | -0.58 % | $ 1.07 B | USA |
 |
Inspire Medical Systems
INSP
|
96.1 M | $ 41.82 | -2.06 % | $ 1.23 B | USA |
 |
Integer Holdings Corporation
ITGR
|
232 M | $ 91.09 | 0.12 % | $ 3.16 B | USA |
 |
Invacare Corporation
IVC
|
220 M | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
1.81 B | $ 85.54 | 0.49 % | $ 50 B | USA |
 |
Sintx Technologies
SINT
|
3.73 M | $ 2.16 | 1.9 % | $ 5.99 M | USA |